AGPV (TFA)

• Description :

  AGPV TFA, a tetrapeptide, has the potential for prevention of schistosome parasite infection research[1].

• UNSPSC :

  12352209

• Target :

  Parasite

• Type :

  Peptides

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/agpv-tfa.html

• Solubility :

  H2O

• Smiles :

  CC(C)[C@@H](C(O)=O)NC([C@H]1N(CCC1)C(CNC([C@@H](N)C)=O)=O)=O.O=C(O)C(F)(F)F

• Molecular Formula :

  C17H27F3N4O7

• Molecular Weight :

  456.41

• References & Citations :

  [1]James H. McKerrow, et al. Synthetic tetrapeptides for the prevention of schistosome parasite infection. US5284829A.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• Isoform :

  Schistosome